Sort
15,273 grants matching “antimicrobial resistance”
Translational development of new agents alone and in combination to combat Gram-negative pathogens important in Ventilator- Associated Bacterial Pneumonia: Leveraging the Gram-negative toolbox that is
$2,308,174George Louis Drusano · University Of Florida · P01 · FY2024 · AI
Systems Epigenomics of Persistent Bloodstream Infection
$2,304,639Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U19 · FY2023 · AI
Support for the NIH Database for Combating Antibiotic Resistance Bacteria
$2,300,000Sandeep Somiaya · Medical Science & Computing, Llc · N02 · FY2018 · OD
Advancing Public Health Research in Bangladesh
$2,298,943Sayera Banu · International Ctr/Diarrhoeal Dis Res · U01 · FY2019 · GH
Harvard-wide Program on Antibiotic Resistance
$2,292,953Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2023 · AI
Randomized Trial of High-Dose Rifampin in Patients with New Smear-Positive TB
$2,289,159Carole D Mitnick · Harvard Medical School · U01 · FY2013 · AI
GENES AND PATHWAYS OF ADAPTIVE ANTIMICROBIAL RESISTANCE
$2,273,182The Leland Stanford Junior University · · FY2010 · Department of Defense
Chemical Biology of Infectious Disease
$2,272,500Phillip Scott Hefty · University Of Kansas Lawrence · P20 · FY2019 · GM
DESIGNED BETA-STRANDS FOR INHIBITING EFFLUX PUMPS AND DISABLING ANTIBIOTIC RESISTANCE
$2,272,500Joanna Sg Slusky · University Of Kansas Lawrence · DP2 · FY2017 · GM
Chemical Biology of Infectious Disease
$2,272,500Phillip Scott Hefty · University Of Kansas Lawrence · P20 · FY2020 · GM
Task Order D-13 PRE-CLINICAL MICROBIOLOGICAL, SAFETY, TOXICOLOGY, AND PHARMACOKINETIC SERVICES
$2,272,027Jon Mirsalis · Sri International · N01 · FY2023 · AI
Harvard-wide Program on Antibiotic Resistance
$2,271,745Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2024 · AI
Malaria Drug Resistance and Disease Virulence
$2,269,751Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Chemical Biology of Infectious Disease
$2,265,277Thomas Edward Prisinzano · University Of Kansas Lawrence · P20 · FY2017 · GM
Phase I Clinical Trial Unit for Therapeutics
$2,261,800Salama Balume · Dynport Vaccine Company, Llc · N01 · FY2014 · AI
Harvard-wide Program on Antibiotic Resistance
$2,252,080Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2025 · AI
Design and Use of Novel Bacteriocins
$2,250,000Shaun Lee · University Of Notre Dame · DP2 · FY2011 · OD
New potent orally bioavailable nitro-containing compounds to treat mycobacterial infections
$2,248,740Robert B Abramovitch · Michigan State University · R01 · FY2025 · AI
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
$2,244,419Beth Diane Kirkpatrick · University Of Vermont & St Agric College · P20 · FY2019 · GM
DECIPHERING NOVEL MECHANISMS OF ANTIMICROBIAL RESISTANCE WITH MASSIVELY PARALLEL COMBINATORIAL GENETICS
$2,232,399Massachusetts Institute Of Technology · · FY2015 · Defense Threat Reduction Agency
Center for Microbial Pathogenesis and Host Inflammatory Responses
$2,227,346Mark S Smeltzer · Univ Of Arkansas For Med Scis · P20 · FY2019 · GM
Center for Microbial Pathogenesis and Host Inflammatory Responses
$2,227,346Mark S Smeltzer · Univ Of Arkansas For Med Scis · P20 · FY2021 · GM
Center for Microbial Pathogenesis and Host Inflammatory Responses
$2,227,346Mark S Smeltzer · Univ Of Arkansas For Med Scis · P20 · FY2020 · GM
Combating Bacterial Drug Resistance by Targeting the Enzymes of Evolution
$2,224,684Rahul Manu Kohli · University Of Pennsylvania · DP2 · FY2012 · GM
Application of Genomic Approaches to Bacterial Pathogenesis and Mechanisms of Antimicrobial Resistance
$2,220,163John Dekker · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI